DEVELOPING A NOVEL THERAPEUTIC STRATEGY TARGETING KALLIKREIN-4 TO INHIBIT PROSTATE CANCER GROWTH AND METASTASIS
$124,056FY2014Department of DefenseDOD
Queensland University Of Technology, Brisbane
Investigators
View source on USAspending →DEVELOPING A NOVEL THERAPEUTIC STRATEGY TARGETING KALLIKREIN-4 TO INHIBIT PROSTATE CANCER GROWTH AND METASTASIS · GrantIndex